ICECURE TO CONDUCT HANDS-ON CRYOABLATION DEVICE TRAINING AT CIRSE 2019, SEPT 10, 12:30-14:00
Register now for our hands-on-device training at the Cardiovascular and Interventional Radiological Society of Europe annual conference on September 10th at 12:30-14:00. Come and learn more about how our next generation liquid nitrogen (LN2) cryoablation system, ProSense™, works to advance the treatment of kidney, lung and bone cancer without surgery. See you there!
ICECURE SUPPORTS THE FIRST-EVER BREAST CANCER LIQUID NITROGEN CRYOABLATION CONFERENCE, SEPT 20-21, 2019, KAMEDA MEDICAL CENTER
Led by leading expert, Professor Eisuke Fukuma, we are proud to support the first-ever breast cancer liquid nitrogen (LN2) cryoablation conference at Kameda Medical Center. Join this must-attend event to hear the latest clinical insights and results from leading doctors using ProSenseTM. Register today to reserve your spot (limited availability). Learn More
ICECURE PLATINUM SPONSOR OF THE 20TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY OF CRYOSURGERY, SEPT 4-5, 2019.
Demonstrating our commitment to advance the treatment of cancer using cryosurgery, we are proud to be the Platinum sponsor of the 20th World Congress of the International Society of Cryosurgery: Sept 4-5, 2019, Haifa, Israel. With talks from top experts sharing their latest clinical findings using our ProSense™ system, come and visit the IceCure booth […]
IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association
New Category III CPT Code expected to support further adoption of minimally invasive cryoablation treatments for breast cancer. Learn more.
IceCure featured in the leading interventional oncology news outlet, Interventional News
IceCure’s landmark US clinical trial, ICE3, for nitrogen-based cryoablation of small, low-risk, early stage malignant breast tumors without subsequently removing them, featured in Interventional News. Cryoablation shows promise in treating low-risk breast cancers. “If the positive preliminary findings are maintained as the patients enrolled in the study continue to be monitored, that will serve as […]
IceCure to attend SIO, 8 June – 11 June 2019
Visit us at The Society of Interventional Oncology’s next scientific meeting, SIO 2019 (WCIO) booth #32, 8-11 June, Boston, USA to learn more about our next generation liquid-nitrogen-based cryoablation system, ProSense. Join us on Monday June 10th for our hands-on ablation workshop at 8:30-10.45am. Read more >
IceCure to attend ASBrS 20th Annual Meeting, 30 April – 5 May 2019
Visit us at the American Society of Breast Surgeons (ASBrS) 20th Annual Meeting. Join us at booth #314 to learn more about our next generation liquid-nitrogen-based cryoablation system, ProSense, and to hear more from our landmark ICE3 breast cancer trial in the US. Read more >